Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


Treatment of pulmonary arterial hypertension

Oral Presentation
Chairs: O. Sitbon (Clamart, France), J. Pepke-Zaba (Cambridge, United Kingdom)


Download all media Download all media
 [+]  Congress or journal article abstract Slide presentation 3125 Deleterious effects of ß-blockers on exercise capacity and hemodynamics in portopulmonary hypertension
S. Provencher, P. Hervé, V. Ioos, X. Jais, D. Lebrec, M. Humbert, G. Simonneau, O. Sitbon (Clamart, Clichy, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 3126 Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy
H. J. Seyfarth, S. Hammerschmidt, H. Pankau, J. Schauer, J. Winkler, H. Wirtz (Leipzig, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 3127 Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients
A. Peacock, G. Burgess, T. Parpia, R. Barst (Glasgow, Sandwich, United Kingdom; New York, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 3128 Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH)
P. Corris, G. Burgess, T. Parpia, R. Barst (Newcastle upon Tyne, Sandwich, United Kingdom; New York, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 3129 Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
O. Sitbon, G. Burgess, T. Parpia, H. Ghofrani (Clamart, France; Sandwich, United Kingdom; Giessen, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3130 Sitaxsentan treatment for patients with pulmonary arterial hypertension (PAH) failing bosentan due to lack of efficacy
R. L. Benza, R. Barst (Birmingham, New York, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3131 STRIDE-2 trial: a placebo-controlled study for sitaxsentan in PAH
N. Galie, D. Langleben, R. Barst (Bologna, Italy; Montreal, Canada; New York, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 3132 Haemodynamics during vasodilator test comparing urapidil and nicardipine to NO in pulmonary arterial hypertension
B. Gressens, D. Castanares, J. Jamart, P. Bulpa, E. Installé, P. Evrard (Yvoir, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite